Unfractionated heparin promotes LPS-induced endothelial barrier dysfunction: A preliminary study on the roles of angiopoietin/Tie2 axis

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages

  Li, Xu ^a   Zheng, Zhen ^a   Mao, Yiran ^a   Ma, Xiaochun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Angiopoietin; Endothelial cells; Permeability; Sepsis; Unfractionated heparin

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; HEPARIN; LIPOPOLYSACCHARIDE; PHOSPHATE BUFFERED SALINE; PROTEIN ZO1;

ARTICLE; CELL ASSAY; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL BARRIER DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IMMUNOBLOTTING; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SEPSIS; SIGNAL TRANSDUCTION; STIMULATION; STRESS FIBER; VASCULAR DISEASE;

ANGIOPOIETINS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; ENDOTHELIUM, VASCULAR; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIPOPOLYSACCHARIDES; RECEPTOR, TIE-2;

EID: 84862792445     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.03.003     Document Type: Article

References (47)

1. R. Medzhitov Toll-like receptors and innate immunity Nat Rev Immunol 1 2001 135 145 [PubMed:11905821]
2. J.L. Imler, and L. Zheng Biology of Toll receptors: lessons from insects and mammals J Leukoc Biol 75 2004 18 26 [PubMed:12960276]
3. D. Chakravortty, N. Koide, and Y. Kato Cytoskeletal alterations in lipopolysaccharide-induced bovine vascular endothelial cell injury and its prevention by sodium arsenite Clin Diagn Lab Immunol 7 2000 218 225 [PubMed:10702496]
4. G. Gutiérrez-Venegas, L.A. Contreras-Marmolejo, and P. Román-Alvárez Aggregatibacter actinomycetemcomitans lipopolysaccharide affects human gingival fibroblast cytoskeletal organization Cell Biol Int 32 2008 417 426 [PubMed:18291687]
5. A.K. Singh, Y. Jiang, and S. Gupta Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation Toxicol Mech Methods 17 2007 331 347 [PubMed:20020957]
6. I. Cinel, and R.P. Dellinger Advances in pathogenesis and management of sepsis Curr Opin Infect Dis 20 2007 345 352 [PubMed:17609592]
7. J.X. Chen, and A. Stinnett Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice Arterioscler Thromb Vasc Biol 28 2008 1606 1613 [PubMed:18556567]
8. E. Iivanainen, L. Nelimarkka, and V. Elenius Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor FASEB J 17 2003 1609 1621 [PubMed:12958167]
9. G. Majno, and G.E. Palade Studies on inflammation.1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study J Biophys Biochem Cytol 11 1961 571 605 [PubMed:14468626]
10. S.M. Opal The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis Int J Med Microbiol 297 2007 365 377 [PubMed:17452016]
11. G. Bazzoni, and E. Dejana Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis Physiol Rev 84 2004 869 901 [PubMed:15269339]
12. J. Waschke, F.E. Curry, and R.H. Adamson Regulation of actin dynamics is critical for endothelial barrier functions Am J Physiol Heart Circ Physiol 288 2005 H1296 H1305 [PubMed:15528228]
13. U. Fiedler, and H.G. Augustin Angiopoietin: a link between angiogenesis and inflammation Trends Immunol 27 2006 552 558 [PubMed: 17045842]
14. N. Jones, K. Iljin, and D.J. Dumont Tie receptors: new modulators of angiogenic and lymphangiogenic responses Nat Rev Mol Cell Biol 2 2001 257 267 [PubMed: 11283723]
15. J.R. Gamble, J. Drew, and L. Trezise Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions Circ Res 87 2000 603 607 [PubMed: 11009566]
16. X. Li, C.N. Hahn, and M. Parsons Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1 Blood 104 2004 1716 1724 [PubMed: 15172966]
17. T. Mammoto, S.M. Parikh, and A. Mammoto Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo J Biol Chem 282 2007 23910 23918 [PubMed: 17562701]
18. S.D. McCarter, S.H. Mei, and P.F. Lai Cell-based angiopoietin-1 gene therapy for acute lung injury Am J Respir Crit Care Med 175 2007 1014 1026 [PubMed: 17322110]
19. S.H. Mei, S.D. McCarter, and Y. Deng Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 PLoS Med 4 2007 e269 [PubMed: 17803352]
20. G. Thurston, J.S. Rudge, and E. Ioffe Angiopoietin-1 protects the adult vasculature against plasma leakage Nat Med 6 2000 460 463 [PubMed: 10742156]
21. B. Witzenbichler, D. Westermann, and S. Knueppel Protective role of angiopoietin-1 in endotoxic shock Circulation 111 2005 97 105 [PubMed: 15611372]
22. P.C. Maisonpierre, C. Suri, and P.F. Jones Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 1997 55 60 [PubMed: 9204896]
23. S.M. Parikh, T. Mammoto, and A. Schultz Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans PLoS Med 3 2006 e46 [PubMed: 16417407]
24. V. Bhandari, R. Choo-Wing, and C.G. Lee Hyperoxia causes angiopoietin 2- mediated acute lung injury and necrotic cell death Nat Med 12 2006 1286 1293 [PubMed: 17086189]
25. J. Hirsh, T.E. Warkentin, and S.G. Shaughnessy Heparin and low-molecular-weight-heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy and safety Chest 119 2001 64S 94S [PubMed: 11157643]
26. K.R. Taylor, and R.L. Gallo Glycosaminoglycans and their proteoglycans: host- associated molecular patterns for initiation and modulation of inflammation FASEB J 20 2006 9 22 [PubMed: 16394262]
27. R.T. Barrow, E.T. Parker, and S. Krishnaswamy Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator J Biol Chem 269 1994 26796 26800 [PubMed:7929416]
28. U. Derhaschnig, T. Pernerstorfer, and M. Knechtelsdorfer Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia Crit Care Med 31 2003 1108 1112 [PubMed:12682480]
29. U.M. Hollenstein, T. Pernerstorfer, and M. Homoncik Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation J Infect Dis 186 2002 1270 1276 [PubMed:12402196]
30. D.J. Tyrell, S. Kilfeather, and C.P. Page Therapeutic uses of heparin beyond its traditional role as an anticoagulant Trends Pharmacol Sci 16 1995 198 204 [PubMed:7652929]
31. N. Harada, K. Okajima, and M. Uchiba Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion- induced liver injury in rats Crit Care Med 34 2006 1883 1891 [PubMed:16641616]
32. A.M. Morrison, P. Wang, and I.H. Chaudry A novel nonanticoagulant heparin prevents vascular endothelial cell dysfunction during hyperdynamic sepsis Shock 6 1996 46 51 [PubMed:8828084]
33. M.C. Yagmurdur, E. Turk, and G. Moray Effect of heparin on bacterial translocation and gut epithelial apoptosis after burn injury in the rat: dose-dependent inhibition of the complement cascade Burns 31 2005 603 609 [PubMed:15993305]
34. Y. Matzner, G. Marx, and R. Drexler The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis Thromb Haemost 52 1984 134 137 [PubMed:6084320]
35. J.A. Freischlag, M.D. Colburn, and W.J. Quiñones-Baldrich Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril J Surg Res 52 1992 523 529 [PubMed:1320173]
36. G. Majno, G.E. Palade, and G.I. Schoefl Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study J Biophys Biochem Cytol 11 1961 607 626 [PubMed:14468625]
37. N. Minhas, M. Xue, and K. Fukudome Activated protein C utilizes the angiopoitin/Tie2 axis to promote endothelial barrier function FASEB J 24 2010 873 881 [PubMed:19858095]
38. J. Hirsh, and R. Raschke Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 2004 188S 203S [PubMed:15383472]
39. J.S. Bae, and A.R. Rezaie Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand Thromb Haemost 100 2008 101 109 [PubMed:18612544]
40. P.S. Tsai, C.C. Chen, and P.S. Tsai Heme oxygenase 1, nuclear factor E2-related factor 2, and nuclear factor kappaB are involved in hemin inhibition of type 2 cationic amino acid transporter expression and L-Arginine transport in stimulated macrophages Anesthesiology 105 2006 1201 1210 [PubMed:17122583]
41. R. Ding, D. Zhao, and R. Guo Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice Thromb Res 128 2011 e160 e165
42. S.R. Crowley The pathogenesis of septic shock Heart Lung 25 1996 124 134 [PubMed:8682683]
43. W.C. Aird The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome Blood 101 2003 3765 3777 [PubMed:12543869]
44. L.O. Mosnier, B.V. Zlokovic, and J.H. Griffin The cytoprotective protein C pathway Blood 109 2007 3161 3172 [PubMed:17110453]
45. J.G. Garcia, A.D. Verin, and K.L. Schaphorst Regulation of thrombin-mediated endothelial cell contraction and permeability Semin Thromb Hemost 22 1996 309 315 [PubMed:8944415]
46. S.E. Orfanos, A. Kotanidou, and C. Glynos Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators Crit Care Med 35 2007 199 206 [PubMed:17110873]
47. M.T. Ganter, M.J. Cohen, and K. Brohi Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg 247 2008 320 326 [PubMed:18216540]